Zobrazeno 1 - 10
of 274
pro vyhledávání: '"Jerzy, Jaroszewicz"'
Autor:
Karol Żmudka, Aleksandra Spychał, Błażej Ochman, Łukasz Popowicz, Patrycja Piłat, Jerzy Jaroszewicz
Publikováno v:
Annales Academiae Medicae Silesiensis, Vol 78, Pp 94-103 (2024)
Introduction: ChatGPT is a language model created by OpenAI that can engage in human-like conversations and generate text based on the input it receives. The aim of the study was to assess the overall performance of ChatGPT on the Polish Medical Fin
Externí odkaz:
https://doaj.org/article/cfc4e20831ab4c69af4bcf71f753bf36
Autor:
Karol Żmudka, Alicja Gałeczka-Turkiewicz, Aleksandra Wroniecka, Aleksandra Włosowicz, Barbara Sobala-Szczygieł, Jolanta Mrochem-Kwarciak, Zenon P. Czuba, Jerzy Jaroszewicz
Publikováno v:
Journal of Clinical Medicine, Vol 13, Iss 7, p 1851 (2024)
Background: Neutrophil gelatinase-associated lipocalin (NGAL) is part of the innate immune system and acute-phase protein. Current data state that acute COVID-19 patients have higher levels of serum NGAL (sNGAL), but it is not known if higher protein
Externí odkaz:
https://doaj.org/article/b6db813db42e4abe9a9f32b4e024bd87
Autor:
Lisa Sandmann, Birgit Bremer, Valerie Ohlendorf, Jerzy Jaroszewicz, Heiner Wedemeyer, Markus Cornberg, Benjamin Maasoumy
Publikováno v:
Viruses, Vol 16, Iss 2, p 255 (2024)
Background: The hepatitis B core-related antigen (HBcrAg) correlates with HBV DNA in patients with chronic HBV infection without antiviral treatment. Its utility in monitoring patients during and after the cessation of nucleos(t)ide analog (NA) treat
Externí odkaz:
https://doaj.org/article/d70548208fc34980b7b2902bda2317a3
Autor:
Piotr Dobrowolski, Aleksander Prejbisz, Alina Kuryłowicz, Alicja Baska, Paweł Burchardt, Krzysztof Chlebus, Grzegorz Dzida, Piotr Jankowski, Jerzy Jaroszewicz, Paweł Jaworski, Karol Kamiński, Agnieszka Kapłon-Cieślicka, Marek Klocek, Michał Kukla, Artur Mamcarz, Agnieszka Mastalerz-Migas, Krzysztof Narkiewicz, Lucyna Ostrowska, Daniel Śliż, Wiesław Tarnowski, Jacek Wolf, Mariusz Wyleżoł, Tomasz Zdrojewski, Maciej Banach, Andrzej Januszewicz, Paweł Bogdański
Publikováno v:
Archives of Medical Science, Vol 18, Iss 5, Pp 1133-1156 (2022)
Externí odkaz:
https://doaj.org/article/1e66b86e00c14ced9dd2ce06d737ab4c
Autor:
Nadiia Kasianchuk, Krystyna Dobrowolska, Sofiia Harkava, Andreea Bretcan, Dorota Zarębska-Michaluk, Jerzy Jaroszewicz, Robert Flisiak, Piotr Rzymski
Publikováno v:
Viruses, Vol 15, Iss 12, p 2395 (2023)
The hepatitis B virus (HBV) continues to cause substantial health and economic burdens, and its target of elimination may not be reached in 2030 without further efforts in diagnostics, non-pharmaceutical prevention measures, vaccination, and treatmen
Externí odkaz:
https://doaj.org/article/a4016fec0fbb4660b21163792d8325ba
Autor:
Natalia Morawiec, Daria Chyra, Adrianna Boroń, Bożena Adamczyk, Jerzy Jaroszewicz, Barbara Sobala-Szczygieł, Monika Adamczyk-Sowa
Publikováno v:
BMC Neurology, Vol 22, Iss 1, Pp 1-6 (2022)
Abstract Background COVID-19, caused by a novel coronavirus SARS-CoV 2 has rapidly developed into pandemic. This infectious disease affecting mainly respiratory system may cause multiple systemic disorders. With increasing number of new infected pati
Externí odkaz:
https://doaj.org/article/bf47df32564b44d7b00589a517e197a5
Autor:
Piotr Rzymski, Maria Pokorska-Śpiewak, Teresa Jackowska, Ernest Kuchar, Aneta Nitsch-Osuch, Małgorzata Pawłowska, Mateusz Babicki, Jerzy Jaroszewicz, Leszek Szenborn, Jacek Wysocki, Robert Flisiak
Publikováno v:
Vaccines, Vol 11, Iss 9, p 1502 (2023)
The COVID-19 pandemic has been met with an unprecedented response from the scientific community, leading to the development, investigation, and authorization of vaccines and antivirals, ultimately reducing the impact of SARS-CoV-2 on global public he
Externí odkaz:
https://doaj.org/article/0f71060992e1402ea0dc2a8e9a61261e
Autor:
Robert Flisiak, Dorota Zarębska-Michaluk, Krystyna Dobrowolska, Marta Rorat, Magdalena Rogalska, Justyna Anna Kryńska, Anna Moniuszko-Malinowska, Piotr Czupryna, Dorota Kozielewicz, Jerzy Jaroszewicz, Katarzyna Sikorska, Agnieszka Bednarska, Anna Piekarska, Piotr Rzymski
Publikováno v:
Journal of Clinical Medicine, Vol 12, Iss 17, p 5572 (2023)
This study aimed to compare the clinical picture of COVID-19 in the initial and later period of Omicron dominance and to identify populations still at risk. A retrospective comparison of the clinical data of 965 patients hospitalized during the early
Externí odkaz:
https://doaj.org/article/dfae005289dd40e3a2729723ca334259
Autor:
Monika Pazgan-Simon, Jerzy Jaroszewicz, Krzysztof Simon, Beata Lorenc, Marek Sitko, Dorota Zarębska-Michaluk, Dorota Dybowska, Magdalena Tudrujek-Zdunek, Hanna Berak, Włodzimierz Mazur, Jakub Klapaczyński, Ewa Janczewska, Anna Parfieniuk-Kowerda, Robert Flisiak
Publikováno v:
Journal of Personalized Medicine, Vol 13, Iss 7, p 1111 (2023)
Introduction: In Poland, active HCV infection affects between 0.4 and 0.5% of the population, i.e., about 150,000 people, while the number of patients with epilepsy is estimated to be 350,000–400,000. Currently available antiviral therapies show li
Externí odkaz:
https://doaj.org/article/9f1c660d27b54c3fbfffadb43ebbca63
Autor:
Justyna Mika, Joanna Tobiasz, Joanna Zyla, Anna Papiez, Małgorzata Bach, Aleksandra Werner, Michał Kozielski, Mateusz Kania, Aleksandra Gruca, Damian Piotrowski, Barbara Sobala-Szczygieł, Bożena Włostowska, Paweł Foszner, Marek Sikora, Joanna Polanska, Jerzy Jaroszewicz
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-13 (2021)
Abstract In the DECODE project, data were collected from 3,114 surveys filled by symptomatic patients RT-qPCR tested for SARS-CoV-2 in a single university centre in March-September 2020. The population demonstrated balanced sex and age with 759 SARS-
Externí odkaz:
https://doaj.org/article/c9873397e3a945eeae1a622bdf8cc0c7